US Patent 9050336 None
Patent 9050336 was granted and assigned to Allergan, Inc. on June, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 1 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+219 characters)
Article
Patent abstract
Botulinum neurotoxin formulated with a hyaluronic acid carrier with increased residency time of the botulinum toxin at a subdermal location and fewer botulinum toxin induced complications or side effects.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09050336 None US Patent 9050336 None
Infobox
Patent Number
0905033600
Patent Number
905033600
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
090503360
Date of Patent
June 9, 2015
0Patent Application Number
134668060
Date Filed
May 8, 2012
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
090503360
Date of Patent
June 9, 2015
0Patent Application Number
134668060
Date Filed
May 8, 2012
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09050336 None
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09050336
Date of patent
June 9, 2015
Patent application number
13466806
Date Filed
May 8, 2012
Patent primary examiner
Find more entities like US Patent 9050336 None
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.